References
- Legro R S, Azziz R, Ehrmann D, Fereshetian A G, O'keefe M, Ghazzi M N. Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. J Clin Endocr Metab 2003; 88: 5137–5144
- Apridonidze T, Essah P A, Iuorno M J, Nestler J E. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocr Metab 2005; 90: 1929–1935
- Leo V D, Marca A L, Petraglia F. Insulin – lowering Agents in the management of polycystic overy syndrome. Endocr Rev 2003; 24: 633–667
- Legro R S, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocr Metab 1998; 83: 2694–2698
- Flier J S. Insulin resistance: the metabolic syndrome X. New Engl J Med 1999; 341: 1402
- Fulghesu A M, Angioni S, Portoghese E, Milano F, Batetta B, Paoletti A M, Melis G B. Failures of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome. Fertil Steril 2006; 86: 398–404
- Zawadzki J K, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Polycystic ovary syndrome, A Dunaif, J R Givens, F Haseltine, G M Merriam. Black well scientific, Boston 1992; 377–384
- Grundy S M, Cleeman J I, Daniels S R, Donato K A, Eckel R H, Franklin B A, Gordon D J, Krauss R M, Savage P J, Smith S C, Jr, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735
- Lergo R S, Castracane V D, Kauffman R P. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004; 59: 141–154
- Genuth S, Alberti K G, Bennett P. Follow-up report on the diagnosis of diabetes mellitus. Diabetes care 2003; 26: 3160
- Robinson S, Henderson A D, Gelding S V, Kiddy D, Niththyananthan R, Bush A, Richmond W, Johnston D G, Franks S. Dyslipidemia is associated with insulin resistance in women polycystic ovaries. Clin Endocrinol 1996; 44: 277–284
- Vrbikova J, Cibula D, Dvorakova K, Stanicka S, Sindelka G, Hill M, Fanta M, Vondra K, Skrha J. Insulin Sensitivity in women with polycystic ovary syndrome. J Clin Endocr Metab 2004; 89: 2942–2945
- Park H R, Choi Y, Lee H J, Oh J Y, Hong Y S, Sung Y A. The metabolic syndrome in young Korean women with polycystic ovary syndrome. Diabetes Res Clin PR 2007; 77S: S243–S246, Available online at www.sciencedirect.com
- Cussons A J, Stuckey B GA, watts G F. Metabolic and cardiovascular risk in the polycystic ovary syndrome. Pract Diabetes Int 2005; 22: 261–265
- Kurioka H, Takahashi K, Miyazaki K. Glucose intolerance in japanese patients with polycystic ovary syndrome. Arch Gynecol Obstet 2007; 275: 169–173
- DeUgarte C M, Bartolucci A A, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 2005; 83: 1454–1460
- Kauffman R P, Baker V M, DiMarino P, Gimpel T, castracane V D. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am J Obstet Gynecol 2002; 187: 1362–1369
- Bahrami A. Evaluation of impaired glucose tolerance and type 2 diabetes mellitus prevalence in PCOS and necessity for screening in patients with PCOS. Iran J Diabetes Lipid Disord; Spring Summer 2004; 3: 141–148
- Sheikholeslami H, Mirdamadi M, Ziaee A, Kani C. Insulin resistance in patients with polycystic ovary syndrome. In European congress of endocrinology. May, 3–72008. Bioscientifica publishers, BerlinGermany, Endocrine Abstracts (2008), 16 P648
- Cibula D. Is insulin resistance an essential component of PCOS? The influence of confounding factors. Hum Reprod 2004; 19: 757–759